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In Plasmodium falciparum-endemic regions, pregnant women are at increased risk 
from malaria, especially during first pregnancy. Malarial parasites are sequestered in 
the intervillous space of the placenta 1, where they multiply and induce an inflammatory 
reaction. Severe placental inflammation has been correlated with adverse pregnancy 
outcomes such as fetal growth restriction, still birth, premature delivery, and possibly 
preeclampsia 2-4. Women develop antibodies against placental parasites during 
their first affected pregnancy and thus acquire resistance to infection in subsequent 
pregnancies 5. Antibodies that block adhesion of parasites to placental chondroitin 
sulfate have been associated with increased birth weights in women with chronic 
malaria 6. 
In this issue of the PNAS, Muehlenbachs et al. provide evidence that a dinucleotide 
repeat polymorphism in the 3’-UTR of the fms-like tyrosine kinase 1 (FLT1) gene may 
be under natural selection in malaria endemic areas because of its effects on adverse 
outcomes of placental malaria 7. The authors have previously shown that elevated 
soluble FLT1 (sFLT1) is associated with chronic placental malaria and gestational 
hypertension in nulliparous women from the same population 8. Intriguingly, elevated 
sFLT1 is also observed in preeclampsia, a hypertensive complication of pregnancy that, 
like placental malaria, is most prevalent in first pregnancies 9.
FLT1 is the receptor for vascular endothelial growth factor (VEGF). sFLT1 is a soluble 
form of the receptor that inhibits VEGF signaling in the vasculature by competing with 
full-length FLT1 for binding to VEGF. VEGF, in addition to it pro-angiogenic role, is                 Karumanchi, et al.
thought to be a pro-inflammatory cytokine acting via FLT1 on circulating monocytes 
10. Therefore, FLT1 and sFLT1 may have opposing effects on inflammation. The 
dinucleotide repeat polymorphism studied by Muehlenbachs et al. was shown to affect 
expression levels of FLT1 in cord blood monocytes: alleles with fewer than 28 repeats 
(S alleles) were associated with greater expression of FLT1 when compared with alleles 
with 28 or more repeats (L alleles). Interestingly, SS fetal genotype was also associated 
with higher levels of sFLT1 in maternal plasma. 
Fewer than expected SS infants were born to first-time mothers and this deficiency 
was most pronounced in the peak malaria season. Moreover, first-time SS mothers 
reported a higher frequency of prior pregnancy loss than LL mothers (with SL mothers 
intermediate), but maternal FLT1 genotype was not associated with history of prior 
pregnancy loss for multiparous mothers. These data suggest that SS fetuses suffered 
disproportionate prenatal losses in the presence of placental malaria. There was an 
interesting interaction between placental malaria and birthweight among first-born 
offspring. SS offspring had the highest rate of low birth weight (LBW) in the presence 
of placental malaria, but the lowest rate in its absence. Placental malaria is associated 
both with intrauterine growth retardation and with preterm delivery 11, and it will 
therefore be useful to determine the relative contributions of these factors to the LBW 
noted in SS infants.
How does SS fetal genotype contribute to the greater incidence of pregnancy loss and 
LBW in malaria-infected pregnancies? For first-time mothers with placental malaria, SS                 Karumanchi, et al.
fetal genotype was associated with increased expression of inflammatory markers in 
the placenta and elevated sFLT1 in maternal plasma. If sFLT1 has anti-inflammatory 
effects, its increased expression may be a response to the greater inflammation of SS 
placentas rather than a cause of the inflammation. Perhaps, the latter is mediated via 
effects of S alleles on the expression of full-length FLT1 rather than sFLT1. It will be 
important to determine how this polymorphism regulates FLT1 vs sFLT1 expression in 
the placenta and other cell types.
The authors provide compelling evidence of natural selection acting on the FLT1 
polymorphism in Tanzania. SS fetuses are subject to higher rates of prenatal loss 
and lower birth weights in infected pregnancies, but SS infants have heavier birth 
weights in the absence of placental malaria. Thus, the balance of selective forces 
should show spatial and temporal variation depending on the incidence of malaria. S 
and L alleles coexist in most human populations, although their relative frequencies 
vary markedly. In particular, L alleles are relatively rare in European and indigenous 
American populations but relatively common in African, East Asian, and Pacific Islander 
populations 12. The frequency of L alleles among northern Europeans (> 5%) is higher 
than that of ‘protective’ alleles of other malaria-associated polymorphisms. Therefore, 
placental malaria may help to explain the geographical variation of allele frequencies, 
but may not be the only selective factor influencing the polymorphism. It will be of great 
interest to test whether repeat length modifies the phenotype of other inflammatory 
disorders previously linked to FLT1 signaling 13 and whether FLT1 genotype influences 
birth weight in other populations.                 Karumanchi, et al.
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